Jasper Therapeutics, Inc. Quarterly Return On Assets in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Jasper Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2020 to Q3 2024.
  • Jasper Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -30.6 %, a 111% decline year-over-year.
  • Jasper Therapeutics, Inc. annual Return On Assets for 2023 was -55.1 %, a 5.61% increase from 2022.
  • Jasper Therapeutics, Inc. annual Return On Assets for 2022 was -58.3 %, a 91.5% decline from 2021.
  • Jasper Therapeutics, Inc. annual Return On Assets for 2021 was -30.5 %, a 21.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -30.6 -16.1 -111% Jul 1, 2024 Sep 30, 2024
Q2 2024 -56.1 +3.74 +6.25% Apr 1, 2024 Jun 30, 2024
Q1 2024 -56.2 +6.69 +10.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -55.1 +3.27 +5.61% Oct 1, 2023 Dec 31, 2023
Q3 2023 -14.5 +29.7 +67.2% Sep 30, 2023
Q2 2023 -59.8 -31.3 -110% Apr 1, 2023 Jun 30, 2023
Q1 2023 -62.8 -38.7 -160% Jan 1, 2023 Mar 31, 2023
Q4 2022 -58.3 -27.9 -91.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44.2 +17.3 +28.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.5 +30.1 +51.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -24.2 +28.2 +53.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -30.5 +8.16 +21.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -61.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 -58.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 -52.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -38.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.